Channel Therapeutics Corporation

CHRO · AMEX
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$16-$3-$2-$2
Dep. & Amort.$1$0$0$0
Deferred Tax-$0$0$0$0
Stock-Based Comp.$3$0$0$1
Change in WC-$3$2$1$1
Other Non-Cash$1$0$0$0
Operating Cash Flow-$15-$0-$1-$1
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$3$0$0$0
Investing Cash Flow$3$0$0$0
Financing Activities
Debt Repay.$0$0$0-$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$27$0$0$0
Financing Cash Flow$27$0$0-$0
Forex Effect$0$0$0$0
Net Chg. in Cash$14-$0-$0-$1
Supplemental Information
Beg. Cash$0$0$1$1
End Cash$14$0$0$1
Free Cash Flow-$15-$0-$1-$1